Amarillo Biosciences, Inc. (AMAR.OB) Releases Report on Australian Oral Interferon Influenza Study
Amarillo Biosciences, Inc. Friday announced that they have submitted a final report on the recently completed 200 subject low-dose oral…
Amarillo Biosciences, Inc. Friday announced that they have submitted a final report on the recently completed 200 subject low-dose oral…
Cinedigm Digital Cinema Corp. is the global leader in the digital cinema industry. The company provides the services, experience, technology…
Vasomedical Inc. rocketed by more than 342.86% today, up $0.24 per share to a price of $0.031 a share. The…
Bank of McKenney reported net income of $448,000, or $0.24 per diluted share, in the first quarter of 2010. The…
Universal Data Management provides a data-centric approach to integrating data protection and improving corporate compliance that allows companies to take…
MMR Information Systems has been chosen by Chartis Inc., a global property-casualty and general insurance organization serving more than 40…
Today’s video takes another look at NPDT. It is time to start looking at Newport as a longer term trade…
Inovio Biomedical Corp. is focused on the design, development and delivery of a new generation of vaccines, called DNA vaccines,…
As the 2011-12 patent drop-off for a majority of solid selling pharma products approaches, and phase III trial products are…
Sino Clean Energy, Inc. reported adjusted net income of $11.0 million, or $0.11 per share, in 2009. The company earned…